Metraipolis › archive › dc_86facf573e70

A phase I/IIa study of auceliciclib in patients with advanced solid tumours and in combination with temozolomide in patients with recurrent/relapsed… — Europe PMC PMID:41581338

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41581338
DOI
10.1016/j.esmoop.2025.106035
License (as archived)
solo-consultazione
Archived
2026-11-06T12:49:23.301Z
SHA-256 of the archived text
797e3fc72164751874f07d3d0bbdde0b58a08fd01399a191e6e3e4d2abddb2dc
Stable URL of this page
https://metraipolis.com/documento/dc_86facf573e70

How to cite

A phase I/IIa study of auceliciclib in patients with advanced solid tumours and in combination with temozolomide in patients with recurrent/relapsed… — Europe PMC PMID:41581338 — Europe PMC (en), https://europepmc.org/article/MED/41581338 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_86facf573e70 (Metraipolis archive dc_86facf573e70, sha256 797e3fc72164751874f07d3d0bbdde0b58a08fd01399a191e6e3e4d2abddb2dc)
BibTeX
@misc{dc86facf573e70,
  title = {A phase I/IIa study of auceliciclib in patients with advanced solid tumours and in combination with temozolomide in patients with recurrent/relapsed… — Europe PMC PMID:41581338},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41581338},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_86facf573e70; sha256 797e3fc72164751874f07d3d0bbdde0b58a08fd01399a191e6e3e4d2abddb2dc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41581338. Agents can read the archived copy with the MCP tool read_document.